Tacalyx

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Tacalyx

Jun 28, 2024, 12:35 | Blog

Over €14 M to Advance Development of Tacalyx's Cancer Therapeutics Targeting TACAs

Tacalyx, a privately held biotech company focused on developing novel anti-TACA (Tumor Associated Carbohydrate Antigens)…

All: 1 Posts: 1 - 100

Immunotherapy for Bladder Cancer: Types, Success Rate, Side Effects & More

Radiotherapy for Anus Cancer: Types, Success Rate, Side Effects And More

World Association for Integrative Oncology (WAIO) and OncoDaily Announce Strategic Partnership to Advance Holistic Cancer Care

Leukemia: Symptoms, Causes, Types, Diagnosis & Treatment

U.S. FDA Approval of Ziihera for the Previously Treated, Unresectable or IHC 3+ Biliary Tract Cancer

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023